What are the lead times for delivery?

Peak season lead time is one month, while off-season is within 15 workdays.

Where is the nearest port for shipping?

The nearest ports are Shanghai, Ningbo, and Shenzhen.

What is the company's background?

Testsea is a national high-tech enterprise established in 2015 with 28 patents.

Testsealabs Quick Results Respiratory Influenza Flu A B Rapid Diagnostic Test Kit

Name: Testsealabs Quick Results Respiratory Influenza Flu A B Rapid Diagnostic Test Kit
Brand: HangZhou Testsea biotechnology Co., Ltd.
SKU: 2194894665

Zhejiang, ChinaHangZhou Testsea biotechnology Co., Ltd.

US$2.20

1,000-4,999 Pieces

US$2.00

5,000+ Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Instrument

Certificate

ISO9001, ISO13485, CE

Model NO.

Cassette

Shelf life

2 Years

OEM

Support

Transport Package

Carton

Specification

25tests/box

Trademark

TESTSEALABS

Origin

China

HS Code

3822190020

Production Capacity

100000000

Key features

ISO Certifications: Certified with ISO9001, ISO13485, and CE standards for quality and safety.

OEM Support: Full OEM service available for customized branding and packaging.

Long Shelf Life: Product shelf life is 2 years ensuring long-term usability.

Advanced R&D Team: Led by doctors and masters with 9 dedicated R&D engineers.

High Production Capacity: Recombinant antigen production capacity reaches 18g per month.

GMP Compliant Facility: Operates within a 2,000 sqm GMP 100,000-level purification workshop.

Patented Technology: Holds 28 patents covering medical diagnosis and food safety testing.

Global Market Reach: Exports to North America, Europe, Asia, Africa, and Latin America.

Company profile

HangZhou Testsea biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2022-04-08Nearest Port: Shanghai, Ningbo, ShenzhenAverage Response Time: ≤11.16h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryTestsea Biotechnology is identified as a China-based limited company in Hangzhou, with records describing it as both a trading company and manufacturer/factory. Its stated capabilities include in-vitro diagnostic, veterinary, rapid-test, reagent, and medical-machine products. The supplier reports ISO 9001 and GMP certification, more than 10 production lines, 50 R&D engineers, 50 quality-control staff, and exports to multiple global regions. It describes three technical platforms and sales coverage exceeding 100 countries and regions. However, the evidence does not establish after-sales performance, financial credibility, or product-customization capability. One record associates the supplier with a 2025 THC urine-test product and a Vietnamese buyer, but this is limited customer evidence and does not independently verify broader performance.

Supplier typeThe supplier is identified as a limited company headquartered in Hangzhou, China, and is described as both a trading company/manufacturer-factory. A separate record characterizes the company nature as a factory, supporting a manufacturing role alongside trading activity.

CertificationsThe supplier reports ISO 9001 and GMP certification under its management-system certifications. These are explicit certifications relevant to quality and manufacturing controls.

R&D capabilityThe supplier states that it develops core innovative raw-material technologies and has established immunological detection, molecular-biology detection, and protein core-sheet inspection platforms. The reported 50 R&D engineers and continuing R&D investment further support an established innovation function.

Production capacityThe supplier reports more than 10 production lines, 50 quality-control staff, a one-month off-peak lead time, and broad diagnostic-product offerings. It also reports 90% export sales and access to Shanghai, Ningbo, and Shenzhen ports, although the stated peak-season fulfillment time of 6–12 months indicates substantial seasonal capacity constraints.

Client casesThe supplier states that its products have been sold in more than 100 countries and regions. A separate record identifies a THC urine-test product and one associated Vietnamese buyer, but it does not provide verifiable case details such as order scale, duration, performance results, or references.